In This Section

New Opportunities in Targeting WNT Signaling

Monday April 08, 2019

2:00 pm - 3:30 pm Eastern Time (ET)

Room W205 A


Chair :

Gunnar Schulte
Karolinska Institutet

W. Matthijs Blankesteijn
CARIM, Maastricht University, The Netherlands

The role of WNT signaling in pathological conditions such as cancer, cardiovascular disease and neurodegeneration is now well established and there is increasing interest in therapeutic exploitation of the pathway. In this symposium we will focus on new developments in WNT signaling activation and the rapidly developing opportunities for targeting the pathway at multiple levels in a context of cancer and cardiovascular disease. Next, the translational perspective will be discussed, followed by three short presentations by junior researchers, selected from the abstracts. The symposium will be concluded by a panel discussion where input from the audience will be addressed.


Gunnar Schulte - Karolinska Institutet

Deeper Insight into FZD Activation Mechanisms Provides a New Link to Cancer

David Virshup - Duke-NUS Medical School

Mudulation of Stem Cell Activity by WNT Signaling in Cancer Therapy

W. Matthijs Blankesteijn - CARIM, Maastricht University, The Netherlands

Interventions in WNT Signaling Stimulate Cardiac Regeneration

Panel Discussion

Last Updated: August 15, 2019
Key Dates
April 6

ASPET Business Meeting and Awards Presentation

April 6-9

ASPET Annual Meeting at EB 2019